好文档 - 专业文书写作范文服务资料分享网站

他汀类药物治疗非痴呆型血管性认知障碍的临床观察

天下 分享 时间: 加入收藏 我要投稿 点赞

他汀类药物治疗非痴呆型血管性认知障碍的临床观察

许晓辉;马聪敏;韩月珍

【期刊名称】《中国实用医刊》 【年(卷),期】2015(000)013

【摘要】目的:观察阿托伐他汀治疗非痴呆型血管性认知障碍患者的疗效。方法将92例非痴呆型血管性认知功能障碍(VCIND)患者随机分为治疗组和对照组,每组46例。对照组给予对症治疗加安慰剂治疗,治疗组除常规治疗外每晚给予阿托伐他汀20 mg,疗程为12个月,采用简易智能状态检查量表(MMSE)、蒙特利尔认知评估量表(MOCA)、临床痴呆量表(CDR)进行治疗前后评分。结果与同组治疗前相比,治疗组治疗6个月后 MMSE、MoCA 和 CDR 评分分值差异未见统计学意义(P >0.05);治疗12个月后 MMSE、MoCA 和 CDR 评分分值差异有统计学意义(P <0.05)。与对照组相比,治疗组治疗6个月后 MMSE、MoCA 和 CDR 评分值差异未见统计学意义(P >0.05),但治疗12个月后 MMSE、MoCA 和 CDR 评分值差异有统计学意义(P <0.05)。两组均未见严重的不良反应。结论阿托伐他汀能改善 VCIND 患者的认知功能,坚持服用、依从性较好的患者治疗效果明显。%Objective To observe the efficacy of the atorvastatin therapy on vascular cognitive impairment no dementia(VCIND). Methods Ninety-two patients with VCIND were devided into treat-ment group and control group,with 46 cases in each group. The patients in treatment group received con-ventional therapy and atorvastatin(20 mg / d),and the patients in control group received conventional therapy and

placebo. The duration of treatment was twelve months. The efficacy was evaluated by mini-mental state examination(MMSE),Montreal cognitive assessment(MoCA)and clinical dementia rating (CDR)before and after treatment. Results There was no significant difference in the score of MMSE, MoCA and CDR in treatment group after six months treatment( P > 0. 05). After treatment for twelve months,the score of MMSE,MoCA and ADL increased significantly in the treatment group,compared with that before treatment(P < 0. 01). There was no significant difference in the score of MMSE,MoCA and CDR between the two group after six months treatment( P > 0. 05). After treatment for twelve months,the score of MMSE,MoCA and ADL increased significantly between the two group(P < 0. 01). There was no serious adverse reaction in all two groups. Conclusions Atorvastatin can improve the cog-nitive function in patients with VCIND. The treatment effect is obvious if patients insist on taking atorvas-tatin and have good compliance.

【总页数】2页(47-48)

【关键词】非痴呆型血管性认知功能障碍;阿托伐他汀;疗效观察 【作者】许晓辉;马聪敏;韩月珍

【作者单位】471009 河南洛阳,郑州大学附属洛阳中心医院神经内科;471009 河南洛阳,郑州大学附属洛阳中心医院神经内科;471009 河南洛阳,郑州大学附属洛阳中心医院神经内科

【正文语种】中文 【中图分类】 【文献来源】

https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-journal-practical-medicine_thesis/0201255180657.html 【相关文献】

1.血管性轻度认知障碍及非痴呆性血管性认知障碍患者局部脑血流量的临床研究 [J], 韩彦青; 梅元武; 李光来

2.补中益气汤合胞磷胆碱钠片治疗非痴呆型血管性认知障碍30例疗效观察 [J], 杨福海; 钟有安

3.他汀类药物治疗血管性认知障碍的Mela分析 [J], 李森; 徐万鹏 4.他汀类药物治疗血管性认知障碍的Meta分析 [J], 李森; 徐万鹏

5.遗忘型轻度认知障碍与非痴呆性血管性认知障碍的认知损害及睡眠障碍特点 [J], 任洪磊; 张楠; 孙庆娜; 邵晶皓; 程焱

以上内容为文献基本信息,获取文献全文请下载

他汀类药物治疗非痴呆型血管性认知障碍的临床观察

他汀类药物治疗非痴呆型血管性认知障碍的临床观察许晓辉;马聪敏;韩月珍【期刊名称】《中国实用医刊》【年(卷),期】2015(000)013【摘要】目的:观察阿托伐他汀治疗非痴呆型血管性认知障碍患者的疗效。方法将92例非痴呆型血管性认知功能障碍(VCIND)患者随机分为治疗组和对照组,每组46例。对照组给予对症治疗加
推荐度:
点击下载文档文档为doc格式
3vf045d93f83hrt8bf1m52amw9lhr30089b
领取福利

微信扫码领取福利

微信扫码分享